CA Van der Weyden, SA Pileri, AL Feldman… - Blood cancer …, 2017 - nature.com
CD30 is a member of the tumor necrosis factor receptor superfamily. It is characteristically expressed in certain hematopoietic malignancies, including anaplastic large cell lymphoma …
J Xie, L Liu, N Mladkova, Y Li, H Ren, W Wang… - Nature …, 2020 - nature.com
Membranous Nephropathy (MN) is a rare autoimmune cause of kidney failure. Here we report a genome-wide association study (GWAS) for primary MN in 3,782 cases and 9,038 …
D Fiore, LV Cappelli, A Broccoli, PL Zinzani… - Nature Reviews …, 2020 - nature.com
Peripheral T cell lymphomas (PTCLs) are a heterogeneous group of orphan neoplasms. Despite the introduction of anthracycline-based chemotherapy protocols, with or without …
D Morgan, M Garg, V Tergaonkar, SY Tan… - Biochimica et Biophysica …, 2020 - Elsevier
The understanding of the impact of the non-canonical NF-κB (nuclear factor kappa-light- chain-enhancer of activated B cells) pathway in several human diseases including …
RL Boddicker, GL Razidlo, S Dasari… - Blood, The Journal …, 2016 - ashpublications.org
Peripheral T-cell lymphomas (PTCLs) represent a heterogeneous group of T-cell malignancies that generally demonstrate aggressive clinical behavior, often are refractory to …
After exiting the thymus, Foxp3+ regulatory T (Treg) cells undergo further differentiation in the periphery, resulting in the generation of mature, fully suppressive effector (e) Treg cells …
SY Ng, N Yoshida, AL Christie, M Ghandi… - Nature …, 2018 - nature.com
T-and NK-cell lymphomas (TCL) are a heterogenous group of lymphoid malignancies with poor prognosis. In contrast to B-cell and myeloid malignancies, there are few preclinical …
Anaplastic large cell lymphomas (ALCLs) represent a relatively common group of T-cell non- Hodgkin lymphomas (T-NHLs) that are unified by similar pathologic features but …
JP Zhang, Z Song, HB Wang, L Lang… - Blood, The Journal …, 2019 - ashpublications.org
The success of programmed cell death protein 1 (PD-1)/PD-L1-based immunotherapy highlights the critical role played by PD-L1 in cancer progression and reveals an urgent …